Monthly Archives: March 2016
The European Human Behaviour and Evolution Association (EHBEA)
London, UK, from 5-8 April The European Human Behaviour and Evolution Association (EHBEA) is an interdisciplinary society that supports the activities of European researchers with an interest in evolutionary accounts of human cognition, behaviour and society. EHBEA
Ribose hydroxyl group summary
Making a good drug against a bad virus better
Human brains do not belong to two distinct types: ‘female brains’ and ‘male brains’
Genes regulating Wolbachia cell division
Detecting nerve gases VX and Tabun with a handheld device
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation
Currently, ischemic stroke (which occurs when a blood vessel carrying blood to the brain is blocked) in patients with atrial fibrillation (AF), an abnormal heart rhythm characterized by rapid and irregular beating, can be successfully prevented with
The use of multisite ultrasound in cardiac arrest – the SESAME-protocol
Sequence of the plant beneficial biocontrol agent Pseudomonas fluorescens DSM 8569
Pseudomonas represents an abundant bacterial group that can live in the soil. In this habitat many organisms like fungi, bacteria, plants or insects live together, often intensively interacting in close communities. The composition of these communities is
Are children, adults and elderly women in Greece meeting dietary intake recommendations?
A paradigm shift in self-cleaning materials
Fishing highly explosive and toxic TNP
Osteopontin is a novel player and potential biomarker in hepatosplenic schistosomiasis mansoni
Ionic liquid solubilities in water: a janus phenomenon
How preparation to touch or grasp alters visual size perception
A cost-effective approach to new drug discovery and chemical safety
Modern lifestyle is highly dependent on the use of thousands of chemicals in the form of life-saving drugs as well as specialty substances like pesticides, herbicides, cosmetics, solvents, etc. Today the discovery of a new drug costs





















